Novolin n and Hospitalisation - a phase IV clinical study of FDA data

Summary:

Hospitalisation is reported as a side effect among people who take Novolin n (insulin susp isophane semisynthetic purified human), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Novolin R, and have Hyperkalemia.

The phase IV clinical study analyzes which people have Hospitalisation when taking Novolin n. It is created by eHealthMe based on reports of 2,495 people who have side effects when taking Novolin n from the FDA, and is updated regularly.

What is Novolin n?

Novolin n has active ingredients of insulin susp isophane semisynthetic purified human. It is often used in diabetes. eHealthMe is studying from 2,535 Novolin n users. Check the latest studies of Novolin n.

What is Hospitalisation?

Hospitalisation is found to be associated with 1,717 drugs and 1,135 conditions by eHealthMe. Check the latest studies of Hospitalisation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

2,495 people reported to have side effects when taking Novolin n.
Among them, 37 people (1.48%) have Hospitalisation.

Among these 37 people:

How long have people been on Novolin n when they have Hospitalisation? *

What is the gender of people who have Hospitalisation when taking Novolin n? *

female: 62.86 %
male: 37.14 %

What is the age of people who have Hospitalisation when taking Novolin n? *

What are other drugs people take besides Novolin n? *

What are other side effects people have besides Hospitalisation? *

Thrombosis (formation of a blood clot inside a blood vessel): 2 people, 5.41%
Memory Loss: 2 people, 5.41%
Gastric Ulcer (stomach ulcer): 1 person, 2.70%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 2.70%
Blood Glucose Increased: 1 person, 2.70%
Cardiac Disorder: 1 person, 2.70%
Consciousness - Decreased: 1 person, 2.70%
Death: 1 person, 2.70%
Diabetes Mellitus Inadequate Control: 1 person, 2.70%
Disease Recurrence: 1 person, 2.70%

What are the existing conditions these people have? *

Hyperkalemia (damage to or disease of the kidney): 4 people, 10.81%
Ulcerative Keratitis (ulcerative inflammation of the cornea): 1 person, 2.70%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 2.70%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 2.70%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 2.70%
Neoplasm Malignant (cancer tumour): 1 person, 2.70%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 2.70%
Haemolytic Anaemia (anaemia due to haemolysis): 1 person, 2.70%
Haemochromatosis (body to absorb more iron than usual from food): 1 person, 2.70%
Dementia (madness): 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Novolin n and have Hospitalisation?

- Check whether Hospitalisation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novolin n:

Novolin n (2,535 reports)

Hospitalisation treatments and more:

Hospitalisation (143,651 reports)

How severe was Hospitalisation and when was it recovered:

Hospitalisation in Novolin n

Expand to all the drugs that have ingredients of insulin susp isophane semisynthetic purified human:

Hospitalisation and drugs with ingredients of insulin susp isophane semisynthetic purified human

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Novolin n:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hospitalisation:

Hospitalisation (1,717 drugs)

Browse all the conditions that are associated with Hospitalisation:

Hospitalisation (1,135 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin susp isophane semisynthetic purified human (the active ingredients of Novolin n) and Novolin n (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.